13 Israeli hostages, 4 foreigners released from captivity in the Gaza Strip, Israeli military says

By Najib Jobain, Samy Magdy And Bassem Mroue, The Associated Press

Hamas released 13 Israelis and four foreigners late Saturday in the second round of swaps under a cease-fire deal, the Israeli military said, after the militant group initially delayed the exchange for several hours and claimed that Israel had violated the terms of a truce deal.

The Israeli military said the released hostages, including four Thais, had been transferred to Israel. They were being taken to hospitals for observation and to be reunited with their families.

Shortly after midnight, Israel began releasing 39 Palestinian prisoners to east Jerusalem and the West Bank as part of the swap that ultimately went through after international mediation efforts.

Released Palestinian woman Shurouq Duwiyat arrived at her home in Jerusalem where joyous family members hugged and kissed her.

“We send a message to our people in Gaza that we stand by your side and support you,” Duwiyat told reporters inside her home.

Also in Jerusalem, Israeli troops evicted journalists who gathered outside the home of Israa Jaabis, who had been imprisoned since 2015 after being convicted of carrying out separate attacks on Israelis. Jaabis suffered severe burns on her face and hands during a bombing attack that also wounded an Israeli police officer.

Hundreds of Palestinians waited in the West Bank town of Beitunia for the arrival of additional prisoners.

The Israeli hostages released Saturday by Hamas included seven children and six women, Prime Minister Benjamin Netanyahu’s office announced. Most of the released hostages were from Kibbutz Be’eri, a community Hamas militants ravaged during their Oct. 7 cross-border attack, a spokesperson for the kibbutz said. The children ranged in age from 3 to 16, and the women ranged from 18 to 67.

It was a bittersweet moment for the residents of Be’eri. A kibbutz spokesperson said all the released hostages either had a family member killed in the Oct. 7 rampage or had left a loved one in captivity in Gaza.

The mother of one of the released hostages, 12-year-old Hila Rotem, remained in captivity, the spokesperson said.

Another, Emily Hand, is a girl whose father believed her to be dead for weeks before finding out she was held as a hostage.

Residents of the kibbutz have been staying together at a Dead Sea hotel since the Oct. 7 attack. A large crowd gathered in a function room at the hotel late Saturday, cheering in excitement as they saw the first images of their loved ones being released.

One classmate of 18-year-old Noga Weiss said there was great excitement about her release.

“I was very nervous when I heard about the delay. I thought something would happen,” the classmate, identified as Zohar, told Channel 13 TV. “It was a great relief when I saw her.”

The last-minute delay had created a tense standoff on the second day of what’s meant to be a four-day cease-fire. By nightfall, as the hostages should have emerged from Gaza, Hamas alleged that the aid deliveries permitted by Israel fell short of what was promised and that not enough of it was reaching northern Gaza — the focus of Israel’s ground offensive and main combat zone. Hamas also said not enough veteran prisoners were freed in the first swap on Friday.

“This is putting the deal in danger,” Osama Hamdan, a senior Hamas official, said in Beirut. But Egypt, Qatar and Hamas itself later said obstacles had been overcome, and Hamas listed six women and 33 teenage boys it said were expected to be released by the Israelis.

While uncertainty around some details of the exchange remained, there was some optimism, too, amid earlier scenes of joyous families reuniting on both sides.

On the first day of the cease-fire, Hamas released 24 of the roughly 240 hostages taken during its Oct. 7 attack on Israel that triggered the war, and Israel freed 39 Palestinians from prison. Those freed in Gaza were 13 Israelis, 10 Thais and a Filipino.

Overall, Hamas is to release at least 50 Israeli hostages, and Israel 150 Palestinian prisoners, during the four-day truce — all women and minors.

Israel has said the truce can be extended an extra day for every additional 10 hostages freed — something U.S. President Joe Biden said he hoped would occur.

Biden spoke Saturday with Amir Sheikh Tamim Bin Hamad Al-Thani and Prime Minister Sheikh Mohammed bin Abdulrahman al Thani of Qatar, the White House said, to discuss “hurdles” to the release of the hostages.

The start of the pause brought quiet for 2.3 million Palestinians reeling from relentless Israeli bombardment that has killed thousands, driven three-quarters of the population from their homes and leveled residential areas. Rocket fire from Gaza militants into Israel also went silent.

War-weary Palestinians in northern Gaza returned to the streets, crunching over rubble between shattered buildings and at times digging through it with bare hands. At the Indonesian hospital in Jabaliya, besieged by the Israeli military earlier this month, bodies lay in the courtyard and outside the main gate.

For Emad Abu Hajer, a resident of the Jabaliya refugee camp in the Gaza City area, the pause meant he could again search through the remains of his home, which was flattened in an Israeli attack last week.

He found the bodies of a cousin and nephew, bringing the death toll in the attack to 19. His sister and two other relatives are still missing.

“We want to find them and bury them in dignity,” he said.

The United Nations said the pause enabled it to scale up the delivery of food, water, and medicine to the largest volume since the resumption of aid convoys on Oct. 21. It was also able to deliver 129,000 liters (34,078 gallons) of fuel — just over 10% of the daily pre-war volume — as well as cooking gas, a first since the war began.

In the southern city of Khan Younis, a long line of people with containers waited outside a filling station. Hossam Fayad lamented that the pause in fighting was only for four days.

“I wish it could be extended until people’s conditions improved,” he said.

For the first time in over a month, aid reached northern Gaza. The Palestinian Red Crescent said 61 trucks carrying food, water and medical supplies headed there on Saturday, the largest aid convoy to reach the area yet. The U.N. said it and the Palestinian Red Crescent were also able to evacuate 40 patients and family members from a hospital in Gaza City to a hospital in Khan Younis.

JOY AND EXPECTATION

In Tel Aviv, several thousand people packed a central square called “the square of the hostages,” awaiting news of the second release.

“Don’t forget the others because it’s getting harder, harder and harder. It’s heartbreaking,” said Neri Gershon, a Tel Aviv resident. Some families have accused Netanyahu’s government of not doing enough to bring hostages home.

In the Balata refugee camp in the West Bank, the family of 16-year-old Wael Mesheh was frantically getting the house ready for his homecoming as part of the second swap. “We are going to hug him so tight,” his mother, Hanadi Mesheh, said by phone.

The first group of freed Israelis included nine women and four children ages 9 and under. They were taken to Israeli hospitals for observation and were declared to be in good condition.

Hours later, 24 Palestinian women and 15 teenage boys held in Israeli prisons in the occupied West Bank and east Jerusalem were freed. The teenagers had been jailed for minor offenses like throwing stones. The women included several convicted of trying to stab Israeli soldiers.

“It’s a happiness tainted with sorrow because our release from prison came at the cost of the lives of martyrs and the innocence of children,” said one released prisoner, Aseel Munir al-Titi.

According to the Palestinian Prisoners’ Club, an advocacy group, Israel is holding 7,200 Palestinians, including about 2,000 arrested since the start of the war.

The war in Gaza has been accompanied by a surge in violence in the Israeli-occupied West Bank. Late Saturday, Palestinian health authorities said four Palestinians were killed in an Israeli military raid in the northern West Bank city of Jenin, hours after another raid in the same area killed the local governor’s 25-year-old son.

A 16-year-old Palestinian boy was also killed by Israeli fire near the city of Ramallah. The Israeli army, which frequently conducts military raids aimed at local militant groups, did not immediately comment.

A LONGER PEACE?

The war erupted when several thousand Hamas militants stormed into southern Israel, killing some 1,200 people, mostly civilians, and taking scores of hostages, including babies, women and older adults, as well as soldiers.

“We will return immediately at the end of the cease-fire to attacking in Gaza, operating in Gaza,” Herzi Halevi, Israeli chief of staff, told soldiers.

Israeli leaders have said they won’t stop until Hamas, which has controlled Gaza for the past 16 years, is crushed. Israeli officials have argued that only military pressure can bring the hostages home. But the government is under pressure from hostages’ families to prioritize the release of the remaining captives.

The Israeli offensive has killed more than 13,300 Palestinians, according to the Health Ministry in the Hamas-run Gaza government. Women and minors have consistently made up around two-thirds of the dead. The figure does not include updated numbers from hospitals in the north, where communications have broken down.

Keep it Factual
Add CityNews Toronto as a trusted source on Google to see more local stories from us.

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

2h ago

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

2h ago

Most Watched Today